Tri-Conference 2008
キ|トウキァュn ョiセPォeクmキ| ヲaツI ームョi/テルァU 、jキ|トウオ{ ク゚ーン ウヲW
キ|トウアNヲPョノカiヲ
Fluidigm
Thermo
Aviva Systems Biology
Biobase
Caprion Proteomics
Expression Analysis
Ingenuity
Scientia Advisors
Theranostics Health
Tripos
Wafer GEN
CROWNBIO
Leomics Associates
PCO
BioCentury
Bio IT World
SCIENCE AAAS
TheScienteist




Mastering Medicinal Chemistry キァュn

[  キァュn   |   ョiセPォeクmキ|   |   1、鬣リ   |   2、鬣リ   |   3、鬣リ   ]

イト5ヲ^ ツ蠹ト、ニセヌェコセヌイ゚ - シミケvテトェォカヌサシ
2008ヲ~3、26。28、

  1. ツ蠹ト、ニセヌ・ヘイ」、ァキ~ャノ・Dュnセヤイ、
  2. ッkオh、ァョラィメセヌイ゚(case study)
  3. ウフェェコサ{・i-キsソo、ニセヌ
  4. ク~コナ、ニセヌ、ァョラィメセヌイ゚(case study)
  5. Cォャィxェ「ッfャrェョ`セッ
  6. ・Nチツゥハッeアw
  7. 、、シマッォクgィtイホ

CONFERENCE TOPICS:

  • Strategies for Productive Medicinal Chemistry

  • Discovery of Pain Therapeutics

  • Chemistry Success Stories - Recent NCE Approvals

  • Oncology Chemistry

  • HCV Inhibitors - Breaking New Ground

  • Novel Inhibitors in Metabolic Disease

  • Targeting CNS

SPEAKERS INCLUDE:

Robert J. Altenbach
Abbott Laboratories

Mark A. Ashwell
ArQule Inc.

Tesfaye Biftu
Merck & Co., Inc.

Christopher Steven Burgey
Merck Research Laboratories

Christopher Burns
Protez Pharmaceuticals

Kevin Chen
Schering-Plough Research Institute

Phill Cowley
Organon Research

Michael P. Dillon
Roche Palo Alto LLC

Philip R. Hamann
Wyeth Research

Dirk Heerding
GlaxoSmithKline

Robert M. Jones
Arena Pharmaceuticals

Robert Kania
Pfizer Inc.

Terence A. Kelly
Boehringer Ingelheim Pharmaceuticals Inc.

Ulrich Klar
Bayer Schering Pharma AG

Chih-Hung 鏑ance・Lee
Abbott

Ping Liu
Merck Research Laboratories

Jonathan S. Mason
Lundbeck Research DK

Thomas A. Miller
Merck Research Laboratories

Mark R. Player, M.D.
Johnson & Johnson PR&D, L.L.C.

David A. Price
Pfizer Global Research and Development

Brock T. Shireman
Johnson & Johnson PR&D, L.L.C.

David B. Smith
Roche Palo Alto LLC

James B. Summers
Abbott Laboratories

Mark J. Suto
Icagen Inc.

Lawrence Woo
University of Bath; and Sterix Ltd., a subsidiary of Ipsen

Catalog(PDF) Download
Schedule

サyィ・ソセワ